SCHEMBL19081001

SCHEMBL19081001

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4cc5oc6c7ccccc7ccc6c5c5c4-c4ccccc4C5(C)C)c4ccccc34)ccc21

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.33
IKBKB O14920 1/20 0.32
CYP1A1 P04798 12/20 0.32
CYP1B1 Q16678 12/20 0.32
KMT2A Q03164 1/20 0.32
CYP1A2 P05177 11/20 0.31
ABCB1 P08183 1/20 0.31
ABCC1 P33527 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
PSMD14 O00487 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
CSNK2A1 P68400 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
XDH P47989 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081014 0.93 PRKDC (0.30) PRKDC
SCHEMBL21687082 0.91 PRKDC (0.34) PRKDCIKBKBCYP1A1CYP1B1KMT2A
SCHEMBL19080722 0.90 CYP1A1 (0.37) PRKDCCYP1A1CYP1B1KMT2ACYP1A2
SCHEMBL19080961 0.89 PRKDC (0.32) PRKDCIKBKBCYP1A1CYP1B1KMT2A
SCHEMBL19080777 0.89 CYP1A1 (0.35) PRKDCCYP1A1CYP1B1KMT2ACYP1A2
SCHEMBL19080739 0.89 CYP1A1 (0.38) PRKDCCYP1A1CYP1B1KMT2ACYP1A2
SCHEMBL19080677 0.88 KMT2A (0.36) PRKDCIKBKBCYP1A1CYP1B1KMT2A
SCHEMBL19080962 0.88 CYP1A1 (0.36) PRKDCCYP1A1CYP1B1KMT2ACYP1A2
SCHEMBL19080143 0.88 PRKDC (0.34) PRKDCIKBKBCYP1A1CYP1B1KMT2A
SCHEMBL24735256 0.88 PRKDC (0.34) PRKDCIKBKBCYP1A1CYP1B1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PRKDC 4719/4885IKBKB 3678/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PRKDC 4719/4885IKBKB 3678/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.